Efficacy and safety of the interleukin-10–fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized, phase IIa clinical trial
2026 · Therapeutic Advances in Gastroenterology · 0 citations
https://doi.org/10.1177/17562848251410784